~56 spots leftby Jan 2027

High-Protein Nutrition for Heart Failure-related Muscle Wasting

(ASTRID-HF Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Tufts Medical Center
Disqualifiers: Pregnancy, LVAD, Cancer, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing whether protein supplements can help patients with heart failure who are losing muscle. The study will compare different amounts of protein to see if it helps build muscle in these patients. Researchers believe that extra protein might counteract the body's muscle-wasting processes.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, you must be on guideline-directed medical therapy unless it's contraindicated or not tolerated.

What data supports the idea that High-Protein Nutrition for Heart Failure-related Muscle Wasting is an effective treatment?

The available research shows that high-protein nutrition can be effective for heart failure-related muscle wasting. In a study with patients suffering from chronic heart failure and cachexia, those who received a high-protein supplement gained weight and improved their quality of life. Specifically, 19 out of 20 patients gained weight after 6 weeks, and 17 out of 19 maintained this gain after 18 weeks. Additionally, there was a significant improvement in their quality of life. This suggests that high-protein nutrition can help improve body weight and overall well-being in these patients.12345

What safety data exists for high-protein nutrition in treating muscle wasting in heart failure?

The research indicates that high-protein nutrition, particularly with leucine-enriched supplements, is generally safe and beneficial for older adults experiencing muscle wasting. Whey protein-enriched supplements are commonly used in clinical settings to preserve lean body mass. Studies suggest that increasing dietary protein intake above the current RDA may help maintain muscle mass in older individuals without adverse effects on renal function. However, long-term studies are needed to confirm the safety and efficacy of these supplements.14678

Is Ensure Max Protein a promising treatment for muscle wasting in heart failure patients?

Ensure Max Protein could be a promising treatment because it helps increase muscle protein, which is important for people with heart failure who often lose muscle. It provides essential nutrients that can help maintain or improve muscle mass.1691011

Research Team

Eligibility Criteria

This trial is for adults aged 18-100 with heart failure and reduced ejection fraction (HFrEF), experiencing muscle wasting. They must be on standard heart failure treatments, have a left ventricular ejection fraction ≤40%, and show signs of severe heart failure like hospitalizations or significant weight loss. Excluded are pregnant women, those with certain muscle disorders, severe kidney issues, allergies to milk/protein/lactose intolerance/galactosemia, or very high body weight/BMI.

Inclusion Criteria

I am on standard treatment for my condition, unless I can't tolerate it.
I have had severe heart failure signs in the last year, like hospital stays or major weight loss.
I am between 18 and 100 years old.
See 1 more

Exclusion Criteria

You are allergic to milk or have trouble digesting milk sugar.
I weigh at least 350 pounds or my BMI is 40 or more.
I have a condition that causes muscle weakness or wasting.
See 2 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive dietary protein supplementation with Ensure products, randomized between no, low, or high-dose groups

6 months
Monthly visits for assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months
2 visits (in-person)

Treatment Details

Interventions

  • Ensure Max Protein (Protein Supplementation)
  • Ensure Original (Protein Supplementation)
Trial OverviewThe study tests if different doses of dietary protein from Ensure(R) products can prevent muscle wasting in patients with HFrEF. Participants will be divided into three groups: one without protein supplementation, one with a low dose, and another with a high dose. The goal is to see if increased dietary protein affects muscle mass in the limbs.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental armExperimental Treatment1 Intervention
30 g/day protein supplementation (1 Ensure Max Protein® bottle)
Group II: No intervention armActive Control1 Intervention
0 g/day protein supplementation (no Ensure bottles)
Group III: Sham comparator armActive Control1 Intervention
9 g/day protein supplementation (1 Ensure Original® bottle)

Ensure Max Protein is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Ensure for:
  • Nutritional supplement for patients with malnutrition, including those with heart failure

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tufts Medical Center

Lead Sponsor

Trials
264
Recruited
264,000+
Michael Dandorph profile image

Michael Dandorph

Tufts Medical Center

Chief Executive Officer since 2022

MBA

Helen Boucher profile image

Helen Boucher

Tufts Medical Center

Chief Medical Officer since 2022

MD, FACP, FIDSA

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

A systematic review of 39 randomized controlled trials involving 4274 participants found that protein and essential amino acid (EAA) supplements may improve fat-free mass, muscle strength, and physical function in older adults, particularly those who are undernourished.
Despite these potential benefits, the studies showed significant variability in results and a high risk of bias, indicating that more high-quality research is needed to establish effective nutritional strategies for maintaining strength and function in aging populations.
Systematic review and meta-analysis of the effect of protein and amino acid supplements in older adults with acute or chronic conditions.Cheng, H., Kong, J., Underwood, C., et al.[2019]
In a study of 178 pre-frail older adults over 3 months, those who received leucine-enriched protein supplementation combined with exercise showed significant improvements in physical function, including gait speed and muscle strength, compared to those who only received nutrition support.
Both the nutrition with exercise and nutrition-only groups experienced reductions in inflammatory biomarkers IL-6 and TNF-α, indicating potential health benefits, although these improvements were not maintained after 6 months.
Impact of exercise and leucine-enriched protein supplementation on physical function, body composition, and inflammation in pre-frail older adults: a quasi-experimental study.Merchant, RA., Chan, YH., Anbarasan, D., et al.[2023]
In a pilot study involving 29 patients with chronic heart failure, an oral nutritional supplement significantly increased body weight and improved quality of life over 6 weeks, with an average weight gain of 2.0 kg (3.1%) and 2.3 kg (3.6%) at 6 and 18 weeks, respectively.
The study showed that most of the weight gain was fat tissue, and there was a notable decrease in serum levels of tumor necrosis factor-α, indicating potential anti-inflammatory effects, highlighting the supplement's clinical benefits for cachectic patients.
The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study.Rozentryt, P., von Haehling, S., Lainscak, M., et al.[2021]

References

Systematic review and meta-analysis of the effect of protein and amino acid supplements in older adults with acute or chronic conditions. [2019]
Impact of exercise and leucine-enriched protein supplementation on physical function, body composition, and inflammation in pre-frail older adults: a quasi-experimental study. [2023]
The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. [2021]
Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence. [2022]
Impairment in walking capacity and myocardial function in the elderly: is there a role for nonpharmacologic therapy with nutritional amino acid supplements? [2008]
mTOR1c Activation with the Leucine "Trigger" for Prevention of Sarcopenia in Older Adults During Lockdown. [2022]
A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly. [2020]
Increasing dietary protein requirements in elderly people for optimal muscle and bone health. [2022]
Consumption of a Specially-Formulated Mixture of Essential Amino Acids Promotes Gain in Whole-Body Protein to a Greater Extent than a Complete Meal Replacement in Older Women with Heart Failure. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Soy-Dairy Protein Blend or Whey Protein Isolate Ingestion Induces Similar Postexercise Muscle Mechanistic Target of Rapamycin Complex 1 Signaling and Protein Synthesis Responses in Older Men. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Nutrition and Sarcopenia. [2015]